(European Society for Medical Oncology) Men and women may need to be treated differently -- at least when it comes to some types of cancer. In an analysis to be presented at the ESMO 2018 Congress in Munich, data was pooled from four UK randomised controlled clinical trials (RCTs) of first line chemotherapy in oesophagogastric (OG) cancer, finding significant differences in a number of important side-effects experienced by male and female patients.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2CRVgIC
No comments:
Post a Comment